MethPrimer: Designing Primers for Methylation PCRs

Overview

Journal Bioinformatics

Publisher Oxford University Press

Specialty Biology

Date 2002 Nov 9

PMID 12424112

Citations 1249

Authors

Long-Cheng Li

Rajvir Dahiya

Affiliations

Soon will be listed here.

Abstract

Motivation: DNA methylation is an epigenetic mechanism of gene regulation. Bisulfite- conversion-based PCR methods, such as bisulfite sequencing PCR (BSP) and methylation specific PCR (MSP), remain the most commonly used techniques for methylation mapping. Existing primer design programs developed for standard PCR cannot handle primer design for bisulfite-conversion-based PCRs due to changes in DNA sequence context caused by bisulfite treatment and many special constraints both on the primers and the region to be amplified for such experiments. Therefore, the present study was designed to develop a program for such applications.

Results: MethPrimer, based on Primer 3, is a program for designing PCR primers for methylation mapping. It first takes a DNA sequence as its input and searches the sequence for potential CpG islands. Primers are then picked around the predicted CpG islands or around regions specified by users. MethPrimer can design primers for BSP and MSP. Results of primer selection are delivered through a web browser in text and in graphic view.

Citing Articles

Integrative genome-wide aberrant DNA methylation and transcriptome analysis identifies diagnostic markers for colorectal cancer.

Shen H, Wang Z, Chen Y, Huang C, Xu L, Tong Y Arch Toxicol. 2025; .

PMID: 40059124 DOI: 10.1007/s00204-025-03990-9.

Reciprocal regulation between DNMT3A/3B and microRNAs miRs-299-3p/-30e is a causal factor for the downregulation of microRNAs targeting androgen receptor in prostate cancer.

Ganapathy K, Harrs C, Harris S, Staklinski S, Khatib A, Park J Heliyon. 2025; 11(3):e41948.

PMID: 39944334 PMC: 11815930. DOI: 10.1016/j.heliyon.2025.e41948.

Promoter Methylation Is Vital for the Anticancer Activity of Withaferin A.

Brane A, Sutko M, Tollefsbol T Int J Mol Sci. 2025; 26(3).

PMID: 39940977 PMC: 11818515. DOI: 10.3390/ijms26031210.

Validating a clinically based MS-MLPA threshold through comparison with Sanger sequencing in glioblastoma patients.

Lhotska H, Janeckova K, Cechova H, Macoun J, Aghova T, Lizcova L Clin Epigenetics. 2025; 17(1):16.

PMID: 39881389 PMC: 11776323. DOI: 10.1186/s13148-025-01822-2.

Molecular Characterization and Expression of in the Sex Reversal of .

Lian Z, Meng F, Xia X, Fang J, Tian H, Hu Q Animals (Basel). 2025; 15(2).

PMID: 39858121 PMC: 11758646. DOI: 10.3390/ani15020122.